The State Drug Administration's announcement on the prescription drug of potassium glucose tablets into non -prescription drugs (No. 52, 2022)

According to the "Administrative Measures for Prescription Medicine and African Medicine (Trial)" (Order No. 10 of the State Drug Administration), after organizing demonstration and review by the State Drug Administration, potassium sulfate potassium glucose tablets are converted from prescription drugs to over -prescription drugs.The list of varieties and its over -the -counter drug manuals is released together.

Relevant drug listing licenses shall submit the amendments to the provincial pharmaceutical supervision and administration department to the provincial drug supervision and management department before April 6, 2023, and shall notify the relevant medical institutions in the instructions in a timely manner, and shall notify the relevant medical institutions in the instructions in a timely manner.Drug management enterprises and other units.

Other contents other than the content of the non -prescription drug instructions are implemented in the instructions beyond the content of the original approval document.If the drug label involves related content, it should be revised together.Drugs who are submitted from the date of filing of drug listing permits shall not continue to use the original drug instructions.

Special announcement.

Attachment: 1. List of varieties

2. A non -prescription drug instructions template

State Drug Administration

July 6, 2022

Source: National Drug Administration

- END -